1. Osmotic drug delivery from asymmetric membrane film-coated dosage forms;am Ende,2000
2. A thermodynamic model for organic and aqueous tablet film coating;am Ende;Pharm. Dev. Technol,2005
3. FDA Center for Drug Evaluation and Research, 2011. Clinical pharmacology and biopharmaceutics review of tofacitinib. NDA203214. Available at:http://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/203214Orig1s000ClinPharmR.pdf. Accessed 6/14/2016.
4. FDA Center for Drug Evaluation and Research, 2015. Clinical pharmacology and biopharmaceutics review of tofacitinib. NDA208246. Available at:https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/208246Orig1s000ClinpharmR.pdf. Accessed 3/21/2017.
5. Guidance For Industry: Extended release Oral Dosage Forms: Development, Evaluation and Application of in Vitro/In Vivo Correlations,1997